跳至主要内容
临床试验/NCT01588119
NCT01588119招募中不适用

Prospective Register Study to Record Safety and Efficacy of New Oral Anticoagulants

GWT-TUD GmbH1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2011年11月最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
GWT-TUD GmbH
入组人数
5,000
试验地点
1

研究概览

简要总结

Patients, who are adjusted to a new oral anticoagulant (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in routine treatment will recorded in this register. Within this register a characterization of patients (with regard to demography and indication) and therapy (with regard to medication, dose and duration) will be done. On basis of defined clinical relevant end points the long-term efficacy and safety will be evaluated.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • indication for treatment with long term anticoagulation
  • initial adjustment or change to nex oral anticoagulant within routine treatment
  • indication for treatment with long term anticoagulation within the register:
  • permanent anticoagulation in arterial fibrillation
  • intended anticoagulation in acute venous thromboembolism for min. 3 months
  • other anticoagulation for min. 3 months within the approved indication

排除标准

  • missing Informed Consent Form
  • missing phone number for telephone follow up
  • contraindication for therapy with new oral anticoagulant (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) according to Summary of Product Characteristics

研究者

发起方
GWT-TUD GmbH
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验